Determination of liposome internal volume with irinotekan

Authors

  • A. V. Stadnichenko National Technical University “Kharkov Polytechnic Institute”, Ukraine
  • Yu. M. Krasnopolskyi National Technical University “Kharkov Polytechnic Institute”, Ukraine
  • V. I. Shvets Moscow State University of fine chemical technology named by M. V. Lomonosov, Russian Federation
  • T. G. Yarnykh National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/ubphj.16.72

Keywords:

liposomes, irinotecan, determination of internal volume, HPLC

Abstract

Were obtained liposomes with irinotecan by “pH gradient” method. To determine the internal volume of liposomes used control method of citrate ion in ultrafiltrate by the HPLC. It was determined that the internal volume of liposomes obtainedis 10.15 % of the total emulsion volume. The method can be used in the development of liposomes by “pH gradient” using citric acid as an internal buffer.

References

Challenges in the clinical development of new antiepileptic drugs. //Valentina Franco, Jacqueline A.French, Emilio Perucca. // Pharmacological Research. Vol. 103, Pp. 95 - 104. 2016.

Human epidermal growth factor receptor-2 antibodies enhance the specificity and anticancer activity of light-sensitive doxorubicin-labeled liposomes. // Qingpo Li, Qin Tang, Peizun Zhang, Zuhua Wang, Tiantian Zhao, Jialin Zhou, Hongrui Li, Qian Ding, Wei Li, Fuqiang Hu, Yongzhong Du, Hong Yuan, Shuqing Chen, Jianqing Gao, Jinbiao Zhan, Jian You. // Biomaterials. Vol. 57. Pp 1 – 11. 2015.

Липосомы в фармации. Продукты нанобиотехнологии. // В. И. Швец, Ю. М. Краснопольский. // Провизор. N 3. Сс. 18-24. 2008.

Remote loading of doxorubicin into liposomes by transmembrane pH gradient to reduce toxicity toward H9c2 cells. // Mohamed Alyane, Gillian Barratt, Mesbah Lahouel. // Saudi Pharmaceutical Journal. Vol. 24, Issue 2. Pages 165–175. 2016.

Reduced cytotoxicity and enhanced bioactivity of cationic antimicrobial peptides liposomes in cell cultures and 3D epidermis model against HSV. // Sapir Ron-Doitch, Beate Sawodny, Andreas Kühbacher, Mirjam M. Nordling David, Ayan Samanta, Jaywant Phopase, Anke Burger-Kentischer, May Griffith, Gershon Golomb, Steffen Rupp. // Journal of Controlled Release. In press. 2016.

Anticancer Potential of Plants and Natural Products: A Review. // Om Prakash, Amit Kumar, Pawan Kumar, Ajeet. // American Journal of Pharmacological Sciences. Vol. 1. No. 6. Pp. 104-115. 2013.

Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity. // Y. Xu, M. A. Villalona-Calero. Annals of Oncology. // Vol.13. Pp. 1841–1851. 2002.

Irinophore C: A liposome formulation of irinotecan with substantially improved therapeutic efficacy against a panel of human xenograft tumors. // Euan C. Ramsay, Malathi Anantha, Jason Zastre, Marieke Meijs, Jet Zonderhuis, Dita Strutt, Murray S.Webb, DawnWaterhouse, Marcel B. Bally. // Clin Cancer Res. Vol. 14 № 4. 2008.

The use of transmembrane pH gradient-driven drug encapsulation in the pharmacodynamic evaluation of liposomal doxorubicin.// D. Mayer, P.R. Cullis, M.B. Bally // Journal of liposome research. Vol.4. Pp. 529 – 533. 1994.

Analysis of the particle size distribution and internal volume of liposomal preparations. //. Elorza, M. A. Elorza, M. C. Sains, and J. R. Chantresx. // Journal of Pharmaceutical Sciences. Vol. 82. No. 1 7. 1993.

Internal volume determination of liposomes by rapid equilibrium technique using hydrogen iodine as a marker. // A. Furman, O. Saygin. // Biotechnology Techniques. Vol. 6. No.4. Pp.299-304. 1992.

Downloads

Published

2016-10-17

Issue

No. 5(46) (2016)

Section

Biopharmaceutical research

License

Copyright (c) 2016 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).